Effect of staurosporine on transcription factor NF-κB in human keratinocytes

Biochemical Pharmacology

Volumn 56, Issue 1, 1998, Pages 71-78

  Chabot Fletcher, Marie ^a   Breton, John J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Interleukin 8; Keratinocytes; NF B; Protein kinase C; Reporter genes; Staurosporine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; RECEPTOR GENE;

BASE SEQUENCE; CELLS, CULTURED; ENZYME INHIBITORS; GENES, REPORTER; HUMANS; INDOLES; INTERLEUKIN-8; KERATINOCYTES; LUCIFERASES; NF-KAPPA B; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; PYRROLES; RNA, MESSENGER; STAUROSPORINE; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0031782807     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00117-8     Document Type: Article

References (39)

1. 2+ dependent protein kinase. Biochem Biophys Res Commun 135: 397-402, 1986.
2. Wilkinson SE and Hallam TJ, Protein kinase C: Is its pivotal role in cellular activation over-stated? Trends Pharmacol Sci 15: 53-57, 1994.
3. Taylor DJ, Evanson JM and Wooley DE, Contrasting effects of the protein kinase C inhibitor, staurosporine, on cytokine and phorbol ester stimulation of fructose 2,6-bisphosphate and prostaglandin E production by fibroblasts in vitro. Biochem J 269: 573-577, 1990.
4. Dornand J, Bouaboula M, Dupuy d'Angeac A, Favero J, Shire D and Casellas P, Contrasting effects of the protein kinase C inhibitor staurosporine in the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line. J Cell Physiol 151: 71-80, 1992.
5. Mahon TM, Matthews JS and O'Neill LA, Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1α in EL4 thymoma cells. Activation of nuclear factor κB as a common signal for staurosporine and interleukin 1α. Biochem J 325: 39-45, 1997.
6. Chabot-Fletcher M, Breton J, Lee J, Young P and Griswold DE, Interleukin-8 production is regulated by protein kinase C in human keratinocytes. J Invest Dermatol 103: 509-515, 1994.
7. Jones KT and Sharpe GR, Staurosporine, a non-specific PKC inhibitor, induces keratinocyte differentiation and raises intracellular calcium, but Ro31-8220 does not. J Cell Physiol 159: 324-330, 1994.
8. Hashimoto S and Hagino A, Staurosporine-induced neurite outgrowth in PC12h cells. Exp Cell Res 184: 351-359, 1989.
9. Morioka H, Ishihara M, Shibai H and Suzuki T, Staurosporine-induced differentiation in a neuroblastoma cell line, NB-1. Agric Biol Chem 49: 1959-1963, 1985.
10. Shoshan MC and Linder S, Induction of the collagenase phorbol ester response element by staurosporine. J Cell Biochem 55: 496-502, 1994.
11. Dierks-Ventling C, Knesel J, Nagamine Y, Hemmings BA, Pehling G, Fischer F and Fabbro D, Staurosporine stimulated expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cells. Int J Cancer 44: 865-870, 1989.
12. Cassatella MA, Aste M, Calzetti F, Constantin G, Guasparri I, Ceska M and Rossi F, Studies on the regulatory mechanisms of interleukin-8 gene expression in resting and IFN-γ-treated neutrophils: Evidence on the capability of staurosporine of inducing the production of interleukin-8 by human neutrophils. Biochem Biophys Res Commun 190: 660-667, 1993.
13. Mukaida N, Shiroo M and Matsushima K, Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 143: 1366-1371, 1989.
14. Mukaida N, Mahe Y and Matsushima Y, Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265: 21118-21133, 1990.
15. Baldwin AS, The NF-κB and IκB proteins: New discoveries and insights. Ann Rev Immunol 14: 649-681, 1996.
16. Hohmann H-P, Remy R, Aigner L, Brockhaus M and van Loon APGM, Protein kinases negatively affect nuclear factor-κB activation by tumor necrosis factor-α at two different stages in promyelocytic HL-60 cells. J Biol Chem 267: 2065-2072, 1992.
17. Bit RA, Davis PD, Elliott LH, Harris W, Hill CH, Keech E, Kumar H, Lawton G, Maw A, Nixon JS, Vesey DR, Wadsworth J and Wilkinson SE, Inhibitors of protein kinase C: 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J Med Chem 36: 21-29, 1993.
18. Chen M-J, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mitcho M and Shalloway D, Induction of E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330: 581-583, 1987.
19. Meyers CA, Johanson KO, Miles LM, McDevitt PJ, Simon PL, Webb RL, Chen M-J, Holskin BP, Lillquist JS and Young PR, Purification and characterization of human recombinant interleukin-1β. J Biol Chem 262: 11176-11181, 1987.
20. Dignam JD, Lebovitz RM and Roeder RG, Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
21. Osborn, L, Kunkel S and Nabel GJ, Tumor necrosis factor α and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 86: 2336-2340, 1989.
22. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
23. Hedberg, KK, Birrell GB, Habliston DL and Griffith OH, Staurosporine induces dissolution of microfilament bundles by a protein kinase C-independent pathway. Exp Cell Res 188: 199-208, 1990.
24. Kunsch C, Lang RK, Rosen CA and Shannon MF, Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J Immunol 153: 153-164, 1994.
25. Sen P and Baltimore D, Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716, 1986.
26. Sen P and Baltimore P, Inducibility of κ immunoglobulin enhancer binding protein NF-κB by a post-translational mechanism. Cell 47: 921-928, 1986.
27. Baeuerle PA and Henkel T, Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179, 1994.
28. Baeuerle PA and Baltimore D, Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53: 211-217, 1988.
29. Baeuerle PA and Baltimore D, IκB: A specific inhibitor of the NF-κB transcription factor. Science 242: 540-546, 1988.
30. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z and Rothe M, Identification and characterization of an IκB kinase. Cell 90: 373-383, 1997.
31. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M, A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554, 1997.
32. Zandi, E, Rothwarf DM, Delhase M, Hayakawa M and Karin M, The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252, 1997.
33. Woronicz JD, Gao X, Cao Z, Rothe M and Goeddel DV, IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278: 866-869, 1997.
34. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li Jw, Young DB, Barbosa M, Mann M, Manning A and Rao A, IKK-1 and IKK-2: Cytokine-activated IαB kinases essential for NF-κB activation. Science 278: 860-866, 1997.
35. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB-M, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA and Peyron J-F, Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 86: 787-798, 1996.
36. Kocher M and Clemetson KJ, Staurosporine both activates and inhibits serine/threonine kinases in human platelets. Biochem J 275: 301-306, 1991.
37. Hecker M, Preiß C and Schini-Kerth VB, Induction of Staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: Role of NF-κB, CREB and C/EBPβ. Br J ∼Pharmacol 120: 1067-1074, 1997.
38. Mondal D, Alam J and Prakash O, NF-κB site-mediated negative regulation of the HIV-1 promoter by CCAAT/ enhancer binding proteins in brain-derived cells. J Mol Neurosci 5: 241-258, 1995.
39. Ruocco MR, Chen X, Ambrosino C, Dragonetti E, Liu W, Mallardo M, De Falco G, Palmieri C, Franzoso G, Quinto I, Venuta S and Scala G, Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6) and NF-κB/Rel transcription factors. J Biol Chem 271: 22479-22486, 1996.